The notion “hepatitis” means inflammation of the liver or its cells, often caused by some virus and accompanied in its initial phase to by symptoms similar to flu: fever, loss of appetite, muscle/joint aches, etc. According to the virus type hepatitis is divided into several types: hepatitis A, В C, D and E. Hepatitis can disappear on its own, but in some cases it can lead to serious liver dysfunctions and severe complications such as fibrosis, liver failure or cancer, cryoglobulinemia, an a lot more.
The world hepatitis drugs market has experienced stable growth over the recent years, driven by the constant increase of demand from developed countries, introduction of new products and technological advancement in the medical industry. It is set to continue growing at a CARG of above 12% through 2015. Gilead Sciences, Merck & Co., GlaxoSmithKline, Bristol-Myers Squibb and Hoffmann-La Roche are amid the key hepatitis market players.
The collection of the research reports found in this catalogue provides an extensive insight into the hepatitis market at different geographical scales. Relevant information on the market size, share, segmentation as well as major factors influencing the market is presented in the researches. The reports offer detailed assessment of the competitive landscape and profile top companies. In addition, discussions of future market prospects for the are at hand in the research reports.
Publications found:
130
Sort by:
Egypt Hepatitis C Testing Market, By Test (Antibody Test, Genotype Test, Viral Load Test, Others) By Technique (Immunoassays, Polymerase Chain Reaction (PCR), Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Others), By Region, Competition Forecast and Opportunities, 2027
US$ 4,000.00
The Egypt Hepatitis C Testing Market is expected to grow at an impressive rate in the forecast period. Hepatitis C is a viral infectious disease affecting the liver, from liver inflammation to liver m...
August 2023
73 pages
France Hepatitis A, B, C, D, E Diagnostics Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
US$ 3,900.00
... report presents a detailed analysis of the Hepatitis diagnostics market in France. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications ...
May 2019
241 pages
Germany Hepatitis A, B, C, D, E Diagnostics Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
US$ 3,900.00
... report presents a detailed analysis of the Hepatitis diagnostics market in Germany. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications ...
May 2019
241 pages
Italy Hepatitis A, B, C, D, E Diagnostics Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
US$ 3,900.00
... report presents a detailed analysis of the Hepatitis diagnostics market in Italy. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of ...
May 2019
241 pages
Japan Hepatitis A, B, C, D, E Diagnostics Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
US$ 3,900.00
... report presents a detailed analysis of the Hepatitis diagnostics market in Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of ...
May 2019
241 pages
Spain Hepatitis A, B, C, D, E Diagnostics Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
US$ 3,900.00
... report presents a detailed analysis of the Hepatitis diagnostics market in Spain. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of ...
May 2019
241 pages
UK Hepatitis A, B, C, D, E Diagnostics Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
US$ 3,900.00
... ,HBVNAT,HBsAg,HCV,Anti-HBc,Anti-HBs,Anti-HAV,Hepatitis Delta,HBc Ag,HBe Ag, andALT/SGPT In addition to test volume and ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA ...
May 2019
241 pages
US Hepatitis A, B, C, D, E Diagnostics Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
US$ 3,900.00
... ,HBVNAT,HBsAg,HCV,Anti-HBc,Anti-HBs,Anti-HAV,Hepatitis Delta,HBc Ag,HBe Ag, andALT/SGPT In addition to test volume and ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA ...
May 2019
241 pages
Global Autoimmune Hepatitis Diagnosis and Treatment Market Forecast, 2018-2023
US$ 3,600.00
... and following segments: 1. Global Autoimmune Hepatitis Diagnosis and Treatment Market by Diagnosis 2. Global Autoimmune Hepatitis Diagnosis and Treatment Market by Treatment 3. Global Autoimmune Hepatitis Diagnosis and Treatment Market by Type 4. Global Autoimmune Hepatitis Diagnosis and Treatment Market ...
January 2019
-
Hepatitis C: Drug Development Pipeline Study, H2 2018
US$ 1,500.00
... cirrhosis or liver cancer. Hepatitis C pipeline comprises of 85 active drugs under active development as of June 2018. Of these, 16 drugs are in Phase 1 and 19 drugs in phase 2. Only 4 drugs progressed to Phase 3. Further ...
June 2018
150 pages
Hepatitis E - Pipeline Review, H1 2018
US$ 2,000.00
... releases. The Hepatitis E (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hepatitis E and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2018
28 pages
Hepatitis Diagnostic Test Market Size, Share & Trends Analysis Report, By Diagnostic Tests (Liver Function, Immunoassays & Nucleic Acid Assays, Imaging, Liver Biopsy), And Segment Forecasts, 2018 - 2025
US$ 5,950.00
... hepatitis diagnostics market is expected to reach USD 6.9 billion by 2025, according to a new report by Grand View Research, Inc. In the past decade, the burden of hepatitis ... rendering a positive impact on the market growth owing to rising demand for diagnostic tests. Furthermore, the adoption of molecular ...
May 2018
90 pages
Hepatitis Treatment Market, 2012 to 2023
US$ 4,400.00
... , Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 Market Outline: Hepatitis Treatment Market Hepatitis is the disease characterized by the inflammation of the ...
January 2018
202 pages
Global Hepatitis C Virus Testing Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
US$ 4,400.00
... hepatitis C virus testing market. Globally, hepatitis C virus testing market is segmented based on technique, test type, end-user. Based on technique, hepatitis C virus testing market is segmented as: Polymerase Chain Reaction Tests Immunoassays Others Based on test, hepatitis C virus testing ...
November 2017
221 pages
Global Hepatitis Drug Market & Clinical Trials Insight 2023
US$ 2,400.00
... Hepatitis C drugs. “Global Hepatitis Drug Market & Clinical Trials Insight 2023” report highlights: Prevalence of Hepatitis Infection Available Drug Classes for Hepatitis Drug Global Hepatitis Drug Market Analysis Global Hepatitis (A,B,C,D & E) Drug Clinical Pipeline Insight Marketed Hepatitis Drug Clinical ...
June 2017
550 pages
Hepatitis C [2016]: Bulletin #3
US$ 1,045.00
... presents key opinion leader (KOL) views on recent developments in the hepatitis C virus (HCV) infection market. Topics covered include: Medivir AB communicating ...
May 2017
-
2017 France Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals--Supplier Shares and Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 3,510.00
... . The report presents a detailed analysis of the Hepatitis diagnostics market in France. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests.Also, the report examines the market applications of DNA ...
March 2017
241 pages
2017 Germany Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals--Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 3,510.00
... . The report presents a detailed analysis of the Hepatitis diagnostics market in Germany. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests.Also, the report examines the market applications of DNA ...
March 2017
241 pages
2017 US Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 3,510.00
... report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests.Also, the report examines the market applications of DNA ...
March 2017
241 pages
2017 Italy Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals--Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 3,510.00
... . The report presents a detailed analysis of the Hepatitis diagnostics market in Italy. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests.Also, the report examines the market applications of DNA ...
March 2017
241 pages
2017 Japan Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals--Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 3,510.00
... . The report presents a detailed analysis of the Hepatitis diagnostics market in Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests.Also, the report examines the market applications of DNA ...
March 2017
241 pages
2017 Spain Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals--Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 3,510.00
... . The report presents a detailed analysis of the Hepatitis diagnostics market in Spain. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests.Also, the report examines the market applications of DNA ...
March 2017
241 pages
2017 UK Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Public Health Labs--Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 3,510.00
... report presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests.Also, the report examines the market applications of DNA ...
March 2017
241 pages
2017 Europe Hepatitis Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 6,210.00
... report $6,900. DataPack (test volumes, sales forecasts, supplier shares) $4,500.The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are ...
March 2017
295 pages
2017 World Hepatitis Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 8,550.00
... analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and ... Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets: Hospitals ...
March 2017
320 pages
2017 Italy Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals-Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 3,120.00
... . The report presents a detailed analysis of the Hepatitis diagnostics market in Italy. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA ...
November 2016
241 pages
2017 Japan Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals-Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 3,120.00
... . The report presents a detailed analysis of the Hepatitis diagnostics market in Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA ...
November 2016
241 pages
2017 France Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals-Supplier Shares and Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 3,120.00
... . The report presents a detailed analysis of the Hepatitis diagnostics market in France. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA ...
November 2016
241 pages
2017 Spain Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals-Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 3,120.00
... . The report presents a detailed analysis of the Hepatitis diagnostics market in Spain. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA ...
November 2016
241 pages
2017 US Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs-Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 3,120.00
... report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA ...
November 2016
241 pages
2017 World Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs-Supplier Shares and Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 4,360.00
... , Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides ... NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA ...
November 2016
320 pages
Hepatitis C: KOL Insight
US$ 7,900.00
... options? Since the launch of Sovaldi (sofosbuvir; Gilead) in 2013, the hepatitis C (HCV) landscape has developed at a rapid pace. The focus has ... report reveals candid insights about the HCV landscape from 12 KOLs in North America and Europe. You’ll learn which treatments KOLs have confidence ... advantage. Update Bulletins include expert insight and analysis based on FirstWord analyst re-engagement with the KOLs after major events such as product ...
August 2016
-
Global Hepatitis C Virus (HCV) Market Report: 2016 Edition
US$ 800.00
Hepatitis C Virus (HCV) is an infection which affects the liver which may ... The key factors which are anticipated to drive HCV market include medical reimbursement because of the therapy ... are analyzed in depth. On the contention front, the global HCV market is reined by few major players namely Gilead Sciences, ...
February 2016
60 pages
Hepatitis C: Update Bulletin [February 2016]
US$ 995.00
... on the latest events that have the potential to shape the hepatitis C virus (HCV) treatment landscape. Topics covered include KOL ... if a short treatment regimen is attractive to KOLs. Key Questions Answered in this Update Bulletin: How do KOLs expect Merck & Co.’s Zepatier (elbasvir and grazoprevir) to be ...
January 2016
-
